<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101505086</journal-id>
<journal-id journal-id-type="pubmed-jr-id">36963</journal-id>
<journal-id journal-id-type="nlm-ta">Sci Transl Med</journal-id>
<journal-id journal-id-type="iso-abbrev">Sci Transl Med</journal-id>
<journal-title-group>
<journal-title>Science translational medicine</journal-title>
</journal-title-group>
<issn pub-type="ppub">1946-6234</issn>
<issn pub-type="epub">1946-6242</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27053772</article-id>
<article-id pub-id-type="pmc">5595216</article-id>
<article-id pub-id-type="doi">10.1126/scitranslmed.aad0623</article-id>
<article-id pub-id-type="manuscript">NIHMS898831</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Cultured networks of excitatory projection neurons and inhibitory interneurons for studying human cortical neurotoxicity</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Xu</surname>
<given-names>Jin-Chong</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="author-notes" rid="FN2">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fan</surname>
<given-names>Jing</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="author-notes" rid="FN2">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Xueqing</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Eacker</surname>
<given-names>Stephen M.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kam</surname>
<given-names>Tae-In</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Li</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yin</surname>
<given-names>Xiling</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhu</surname>
<given-names>Juehua</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chi</surname>
<given-names>Zhikai</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jiang</surname>
<given-names>Haisong</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Rong</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dawson</surname>
<given-names>Ted M.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dawson</surname>
<given-names>Valina L.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A5">5</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD</aff>
<aff id="A2">
<label>2</label>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD</aff>
<aff id="A3">
<label>3</label>Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD</aff>
<aff id="A4">
<label>4</label>Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD</aff>
<aff id="A5">
<label>5</label>Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, MD</aff>
<aff id="A6">
<label>6</label>Department of Neurology, Jinling Hospital, Nanjing University School of Medicine, 305 East Zhongshan Road, Nanjing, Jiangsu 210002, China</aff>
<author-notes>
<corresp id="FN1"><label>*</label>Valina L. Dawson, Ph.D. or Ted M. Dawson, M.D., Ph.D., Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering Department of Neurology, Johns Hopkins, University School of Medicine, 733 N. Broadway, Suite 731, Baltimore, MD 21205, U.S.A., Phone: 410-614-3359, Fax: 410-614-9568, <email>vdawson@jhmi.edu</email> or <email>tdawson@jhmi.edu</email></corresp>
<fn fn-type="equal" id="FN2">
<label>†</label>
<p id="P1">These authors contributed equally to this work.</p>
</fn>
<fn fn-type="COI-statement" id="FN4">
<p id="P41"><bold>Competing interests:</bold> The authors declare no competing interests.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>11</day>
<month>8</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<day>06</day>
<month>4</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>12</day>
<month>9</month>
<year>2017</year>
</pub-date>
<volume>8</volume>
<issue>333</issue>
<fpage>333ra48</fpage>
<lpage>333ra48</lpage>
<!--elocation-id from pubmed: 10.1126/scitranslmed.aad0623-->
<abstract>
<p id="P2">Translating neuroprotective treatments from discovery in cell and animal models to the clinic has proven challenging. To reduce the gap between basic studies of neurotoxicity and neuroprotection and clinically relevant therapies, we developed a human cortical neuron culture system from human embryonic stem cells (ESCs) or inducible pluripotent stem cells (iPSCs) that generated both excitatory and inhibitory neuronal networks resembling the composition of the human cortex. This methodology used timed administration of retinoic acid (RA) to FOXG1 neural precursor cells leading to differentiation of neuronal populations representative of the six cortical layers with both excitatory and inhibitory neuronal networks that were functional and homeostatically stable. In human cortical neuron cultures, excitotoxicity or ischemia due to oxygen and glucose deprivation led to cell death that was dependent on N-methyl-D-aspartate (NMDA) receptors, nitric oxide (NO), and the poly (ADP-ribose) polymerase (PARP)-dependent cell death, a cell death pathway designated parthanatos to separate it from apoptosis, necroptosis and other forms of cell death. Neuronal cell death was attenuated by PARP inhibitors that are currently in clinical trials for cancer treatment. This culture system provides a new platform for the study of human cortical neurotoxicity and suggests that PARP inhibitors may be useful for ameliorating excitotoxic and ischemic cell death in human neurons.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>